Presence of human immunodeficiency virus (HIV) and T-lymphotropic virus type I and II (HTLV-I/II) in a haemophiliac population in Belo Horizonte, Brazil, and correlation with additional serological results

Haemophilia

Volumn 4, Issue 1, 1998, Pages 47-50

  Carneiro Proietti, A B F ^a   Lima Martins, M V C ^a   Passos, V M A ^a,c   Carmo, R A ^a   Pinheiro, S R ^b   Rocha, P R M ^b   Proietti, F A ^b   Ferreira, P C P ^b   Rocha, V G ^a,d  

^a FUNDAÇÃO HEMOMINAS   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d SAINT LOUIS HOSPITAL   (France)

Author keywords

AIDS; Blood transmittable diseases; Brazil; Haemophilia; HIV; HTLV

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTERIAL INFECTION; BRAZIL; COMPARATIVE STUDY; HEMOPHILIA A; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; ISOLATION AND PURIFICATION; MIDDLE AGED; PREVALENCE; SEROLOGY; VIROLOGY;

ADOLESCENT; ADULT; BRAZIL; HEMOPHILIA A; HEPACIVIRUS; HEPATITIS B VIRUS; HIV; HIV SEROPREVALENCE; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; MIDDLE AGED; PREVALENCE; SEROLOGIC TESTS; TREPONEMAL INFECTIONS;

EID: 0031598554     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.1998.00128.x     Document Type: Article

References (17)

1. Desforges JF. AIDS and preventive treatment in hemophilia. N Engl J Med 1983; 308: 94-5.
2. Seeff LB, Hoofnagle J. Chronic hepatitis in hemophilia. Ann Intern Med 1977; 86: 818-20.
3. Allain JP, Dailey SH, Laurian Y, et al. Evidence for persistent hepatitis C virus (HCV) infection in hemophiliacs. J Clin Invest 1991; 88: 1672-9.
4. Holman RC, Rhodes PH, Chorba TL, Evatt BL. Survival of hemophilic males with acquired immunodeficiency syndrome with and without risk factors for AIDS other than hemophilia. Am J Hem 1992; 39: 275-82.
5. Hilgartner MW. AIDS and hemophilia. N Eng J Med 1987; 317: 1153-4.
6. Evatt BL, Ramsey RB, Lawrence DN, Zyla LD, Curran JW. The acquired immunodeficiency syndrome in patients with hemophilia. Ann Intern Med 1984; 100: 499-504.
7. Fricke W, Augustyniak L, Lawrence D, Brownstein A, Kramer A, Evatt B. Human immunodeficiency virus infection due to clotting factor concentrates: results of the Seroconversion Surveillance Project. Transfusion 1992; 32: 707-9.
8. Ragni MV, Nimorwicz P. Human immunodeficiency virus transmission and hemophilia. Arch Intern Med 1989; 149: 1379-80.
9. Ming-Ching S, Fuei-Yuen L, Yen-Ping K, Ron-Fon H. A longitudinal study of immunological status in Chinese haemophiliacs: importance of the heat viral inactivation of factor concentrates. I. Immunological associations with the consumption of factor concentrates. Haemophilia 1995; 1: 243-8.
10. Proietti FA, Proietti ABFC, Costa MFFL, et al. Exposure to acellular blood products and risk of HIV infection in hemophiliacs from Belo Horizonte, Brazil. Rev Inst Med Trop São Paulo 1992; 34: 227-32.
11. Sandler SG, Fang C, Williams A. Retroviral infections transmitted by blood transfusion. Yale J Biol Med 1990; 63: 353-60.
12. Schmunis GA. Trypanosoma cruzi, the etiologic agent of Chagas' Disease: status in the blood supply in endemic and non-endemic countries. Transfusion 1991; 31: 547-77.
13. Ward JW, Holmberg SD, Allen JR, et al. Transmission of human immunodeficiency virus (HIV) by blood transfusion screened as negative for HIV antibody. N Eng J Med 1988; 318: 473-8.
14. Proietti FA, Lima-Martins MVC, Passos VMA, Brener S, Carneiro-Proietti ABF. HTLV-I/II seropositivity among eligible blood donors from Minas Gerais State, Brasil. Vox Sang 1994; 67: 77.
15. Lairmore MD, Jason JM, Hartley TM, Khabbaz RF, De B, Evatt BL. Absence of human T-Cell lymphotropic virus type I coinfection in human immunodeficiency virus-infected hemophilic men. Blood 1989; 74: 2596-9.
16. Canavaggio M, Leckie G, Allain JP, et al. The prevalence of antibody to HTLV-I/II in United States plasma donors and in United States and French hemophiliacs. Transfusion 1990; 30: 780-2.
17. Dekaban G, Inwood M, Waters D, Drouin J, Teitel J. Absence of human T-Lymphotropic virus types I and II infection in an Ontario hemophilia population. Transfusion 1992; 32: 513-6.